Navigation Links
Kitware to Develop Novel Neuroimage Processing Methods for Traumatic Brain Injury

Clifton Park, NY (PRWEB) January 23, 2013

Kitware, a leading-edge medical imaging R&D provider, today announces the award of $296,676 in NIH Phase I STTR funding for the development of new neuroimage processing methods for the assessment and improved treatment of traumatic brain injury (TBI).

Nearly 1.7 million Americans suffer TBI annually as a result of car accidents, blunt trauma, gunshots, military combat, and other head traumas. Many who experience TBI require surgical intervention, and in some cases, require daily assistance for years post-injury. Healthcare costs associated with current TBI treatment exceed $60 billion a year; however, existing analytic assessment methods fall short of clinical need. Clinicians require informative metrics and easy-to-use image analysis tools capable of handling large, heterogeneous pathologies that cause severe brain deformations.

To address these critical needs, Kitware will collaborate with Dr. Marc Niethammer at the University of North Carolina, Chapel Hill and Dr. Jack Van Horn at the University of California, Los Angeles (UCLA). The team will leverage computational methods for segmenting, registering, and interpreting images that contain large and changing pathologies to better characterize injury, quantify longitudinal changes, predict outcomes, and support patient treatment management. At Kitware, Stephen Aylward, Senior Director of Operations, North Carolina, is the Principal Investigator; he will work closely with Project Leader Danielle Pace, a Research and Development Engineer at Kitware.

The team will perform multimodal brain image segmentation for the assessment of acute and chronic TBI for measuring damage over a period of time; develop a new deformable image registration method for identifying acute and chronic TBI and change measurement; and investigate novel TBI metrics for predicting outcomes and guiding clinical decision making using multivariate statistics. The resulting software will be delivered to clinicians and made freely available for widespread use and future extension within the open-source 3D Slicer application (

“We are thrilled to have the opportunity to address such a critical medical need,” said Danielle Pace, Project Leader. “Through our exploration of TBI and new analytical and statistical methods for better understanding its effects across groups of individuals over time, clinicians will be empowered to more easily examine patient-specific profiles of TBI and make more informed decisions in regards to treatment.”

For more information on Kitware’s medical computing expertise and how it can be leveraged to benefit your organization, please contact kitware(at)kitware(dot)com.

About Kitware
Kitware is an open-source solutions provider for research facilities, government institutions, and corporations worldwide. Founded in 1998, Kitware specializes in research and development in the areas of visualization, medical imaging, computer vision, quality software process, data management, and informatics. Kitware is headquartered in Clifton Park, NY, with offices in Carrboro, NC, Santa Fe, NM, and Lyon, France. More information can be found at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kitware Announces Opening of Santa Fe Office
2. Kitware Develops Novel System for Autonomous Robot Navigation
3. NASA develops super-black material that absorbs light across multiple wavelength bands
4. Gated STED -- developing the next generation of super-resolution microscopes
5. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
6. Multidisciplinary team of researchers develop world’s lightest material
7. UCLA team develops highly efficient method for creating flexible, transparent electrodes
8. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
9. Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
10. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
11. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
Post Your Comments:
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" ... , President and Chief Executive Officer of ProMetic, will be ... th Annual Healthcare Conference to be held at the ... st , at 8.50am (ET) and ProMetic,s management team ... presentation will be available live via a webcast accessible at ...
(Date:11/24/2015)... 2015 HemoShear Therapeutics, LLC, a privately ... metabolic disorders, announced today the appointment of ... Directors (BOD). Mr. Watkins is the former president ... (HGS), and also served as the chairman of ... , Chairman and CEO of HemoShear Therapeutics. "The ...
(Date:11/24/2015)... YORK , November 24, 2015 ... in a European healthcare ... which the companies will work closely together in identifying European ... unmet medical need. The collaboration is underpinned by a significant ... fund. This is the first investment by Bristol-Myers Squibb in ...
Breaking Biology Technology:
(Date:11/19/2015)... YORK , Nov. 19, 2015  Although some ... market is dominated by a few companies, according to ... companies own 51% of the market share of the ... The World Market for Molecular Diagnostic s ... "The market is still controlled by one company ...
(Date:11/17/2015)... PARIS , November 17, 2015 ... 17 au 19 novembre  2015.  --> Paris ... 2015.  --> DERMALOG, le leader de l,innovation ... à la fois passeports et empreintes sur la même ... pour les passeports et l,autre pour les empreintes digitales. ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
Breaking Biology News(10 mins):